Stocks in play: Think Research Corporation
Announced today that it has appointed Jeffrey Orridge to its Board of Directors. Orridge is a proven leader with a background in Software-as-a-Service ("SaaS"), Artificial Intelligence, brand marketing, and government. Think Research Corporation shares V.THNK are trading unchanged at $0.26.
Read:
The Fight Against Pancreatic Cancer Just Gained a New Ally with $200M VC Firm
Canada’s Gold Sector Gaining Boosts from Several Promising Quebec Projects and Mines
Time Bomb Ticking as Surplus in Carbon Offset Credits on Path Towards Huge Shortage
Breakthroughs in Pancreatic Cancer Treatment: How FDA Designations are Changing the Game